None listed
Conditions
Interventions
None listed
Sponsors
Korea Centers for Disease Control and Prevention
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed as hypertrophic cardiomyopathy 2. Family members of diagnosed patients 3. In cases of juvenile, above age-13(yrs) Patients (male or female) who is diagnosed as hypertrophic cardiomyopathy following the guidlines, were to be asked and voluntarily participated with signing the consent to participate in research - Guidelines a. (Adults) Without the effect of hypertrophy-causing cardiac risks (fabry disease, danon disease, glycogen storage disease, etc.), maximal wall thickness (MWT) are increased more than 15mm in left ventricle with the echocardiography result. b. (in juveniles(age-13 and above)) MWT are relatively increased as adults with regard to body surface area, and not dilated.
Exclusion criteria
Exclusion criteria: - Patients and family members who disagreed with the participation of research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Types of Cardiomyopathy (CMP) | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient's pedigree infomation | — |
Countries
Korea, Republic of
Contacts
Public ContactSeok-Min Kang
Yonsei University Health System, Severance Hospital
Outcome results
None listed